Search results for: 'cell ad g01e therapeutics market'

17 Sep 2024  |  Global  |  Market Research

ADAS and AD Sensor Suite Strategies, Europe, 2024 2030

OEMs Strategies Will Drive Transformational Growth by Using LiDAR as a Primary Sensor with Cameras and Imaging Radar to Meet the Rise of Eyes-off Driving

Infographics

×

Key Issues Addressed

The global automotive industry is going through a transformation with the convergence of the connected, autonomous, shared, and electric (CASE) trends. Connectivity and autonomous driving (AD) features are leading this transformation. Globally, OEMs are looking to introduce various advanced driver assistance system (ADAS) features ranging from L0 t...

The analysis explores the global passenger fuel cell electric vehicle (FCEV) ecosystem, delving into emerging industry growth and consumer demand trends, supportive government policies, and technological advancements. By scrutinizing sales industry data and forecasts, we aim to discern patterns indicative of FCEV adoption worldwide. Our explorat...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

Solar energy constituted 65% of the total 295 GW installed renewable capacity in 2022. About 70% of the deployed solar panels were monofacial panels that generate electricity from only the top side of the panel. Despite their popularity, these monofacial panels have encountered challenges related to space efficiency, energy yield, and dependence on...

The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...

20 Dec 2022  |  Global  |  Technology Research

Advances and Growth Opportunities in RNA Vaccines

Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

Infographics

×

RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

The sleep apnea therapeutics market has witnessed constant growth in the last decade due to the penetration of conventional therapies in untapped regions of the world. However, it is the technological advancements that have led to the emergence of a number conventional therapies for sleep apnea treatment. Increasing patient non-compliance towards t...